Page 2 - Unrolling News Today

–Multiple vepdegestrant studies enrolling globally, including Phase 1, 2, and 3 studies– – Preliminary data from the Phase 1b combination trial of vepdegestrant + palbociclib... | May 5, 2023

Completed enrollment for Phase 2 SEQUEL trial in mild-to-moderate Alzheimer’s disease ; topline results expected 2Q 2023 SHINE trial currently enrolling patients with first patient in Spain... | May 4, 2023

Enrolls Robert LeonardsonRENO, Nev., April 11, 2023 -- NuLegacy Gold is pleased to report enrolling the renowned Mr. Robert Leonardson, BSGE, MSG, Michigan Tech thus adding another member of the... | April 11, 2023

-- CaMMouflage Phase 1 trial for CB-011 enrolling patients with r/r MM at dose level 1 -- BERKELEY, Calif., April 04, 2023 -- Caribou Biosciences, Inc. , a leading clinical-stage CRISPR... | April 4, 2023

U.S. Food & Drug Administration approves enrolling pediatric patients in the ongoing OCU400 Phase 1/2 trial who have: 1) RP associated with NR2E3 and RHO mutations and 2) LCA associated with... | March 27, 2023

>> yeah. >> its like youre watching a spy novel, and youre thinking this is a reality show. but its real. and im just wondering how you felt watching this happen as the cameras were rolling and saying, wow, this is real life unrolling in front of me. >> you know, its this extraordinary thing when youre making a documentary. sometimes you find yourself in these unbelievable places, in these unbelievable situations. and i think this film especially embodies the spirit of that. here i was, a guy fr...

The Supreme Court on Friday directed a medical college in Maharashtra to deposit a penalty of Rs 2.5 crore with AIIMS for over-reaching its order and despite a stay order admitting 100 MBBS students.

EQS-News: Organicell Regenerative Medicine, Inc. OTCMKTS: OCEL - Organicell Starts Enrolling Long COVID Trial 22.11.2022 / 17:33 CET/CEST The issuer is solely responsible

Clinical Trial UpdateMIAMI, FL / ACCESSWIRE / November 17, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB: OCEL), a clinical-stage biopharmaceutical company focused on the development of innovative

New York City Opens Another Hotel For Bused-In Migrants BY THE CENTER SQUARE NOVEMBER 4, 2022 AT 11:16AM By Steve Bittenbender (The Center Square) The